Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-24 @ 11:44 PM
NCT ID:
NCT06112951
Eligibility Criteria:
Inclusion Criteria:
* Bilateral lung transplantation
* dnDSAs \> 3 months with a MFI \> 1000
* No signs of allograft dysfunction
* Alemtuzumab induction therapy
Exclusion Criteria:
* Inclusion in other studies
* Retransplantation
* Multi-organ transplantation
* \> 12 months after transplantation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06112951
Study Brief:
Protocol Section:
NCT06112951